Mutation of the MENIN gene in sporadic pancreatic endocrine tumors

Cancer Research

Volumn 58, Issue 19, 1998, Pages 4417-4420

  Wang, Eric H ^a   Ebrahimi, Sam A ^a   Wu, Allan Y ^a   Kashefi, Carol ^a   Passaro Jr , Edward ^a   Sawicki, Mark P ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Department of Surgery ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER RISK; CHROMOSOME 11Q; GENE MUTATION; HUMAN; HUMAN TISSUE; HYPOPHYSIS ADENOMA; MULTIPLE ENDOCRINE NEOPLASIA; PANCREAS TUMOR; PARATHYROID HYPERPLASIA; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

AMINO ACID SUBSTITUTION; BASE SEQUENCE; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 11; CLONING, MOLECULAR; DNA PRIMERS; EXONS; GASTRINOMA; GENES, TUMOR SUPPRESSOR; HUMANS; INSULINOMA; LOSS OF HETEROZYGOSITY; MULTIPLE ENDOCRINE NEOPLASIA TYPE 1; NEOPLASM PROTEINS; PANCREATIC NEOPLASMS; POINT MUTATION; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; PROTO-ONCOGENE PROTEINS; SEQUENCE DELETION;

EID: 0032190114     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Thompson, N. W. The surgical management of hyperparathyroidism and endocrine disease of the pancreas in the multiple endocrine neoplasia type 1 patient. J. Intern. Med., 238: 269-280, 1995.
2. Service, F. J., McMahon, M. M., O'Brien, P. C., and Ballard, D. J. Functioning insulinoma-incidence, recurrence, and long-term survival of patients: a 60-year study. Mayo Clin. Proc., 66: 711-719, 1991.
3. Stabile, B. E., and Passaro, E. Benign and malignant gastrinomas. Am. J. Surg., 149: 144-150, 1985.
4. Weber, H. C., Venzon, D. J., Lin, J. T., Fishbein, V. A., Orbuch, M., Strader, D. B., Gibril, F., Metz, D. C., Fraker, D. L., and Norton, J. A. Determinants of metastatic rate and survival in patients with Zollinger-Ellison syndrome: a prospective long-term study. Gastroenterology, 108: 1637-1649, 1995.
5. Eubanks, P. J., Sawicki, M. P., Samara, G. J., Gatti, R., Nakamura, Y., Tsao, D., Johnson, C., Hurwitz, M., Wan, Y. J., and Passaro, E. J. Putative tumor-suppressor gene on chromosome 11 is important in sporadic endocrine tumor formation. Am. J. Surg., 167: 180-185, 1994.
6. Lubensky, I. A., Debelenko, L. V., Zhuang, Z., Emmert-Buck, M. R., Dong, Q., Chandrasekharappa, S., Guru, S. C., Manickam, P., Olufemi, S. E., Marx, S. J., Spiegel, A. M., Collins, F. S., and Liotta, L. A. Allelic deletions on chromosome 11q13 in multiple tumors from individual MEN1 patients. Cancer Res., 56: 5272-5278, 1996.
7. Debelenko, L. V., Zhuang, Z., Emmert-Buck, M. R., Chandrasekharappa, S. C., Manickam, P., Guru, S. C., Marx, S. J., Skarulis, M. C., Spiegel, A. M., Collins, F. S., Jensen, R. T., Liotta, L. A., and Lubensky, I. A. Allelic deletions on chromosome 11q13 in multiple endocrine neoplasia type 1-associated and sporadic gastrinomas and pancreatic endocrine tumors. Cancer Res., 57: 2238-2243, 1997.
8. Sawicki, M. P., Wan, Y. J. Y., Johnson, C. L., Berenson, J., Gatti, R., and Passaro, E. Loss of heterozygosity on chromosome 11 in sporadic gastrinomas. Hum. Genet., 89: 445-449, 1992.
9. Radford, D. M., Ashley, S. W., Wells, S. A., Jr., and Gerhard, D. S. Loss of heterozygosity of markers on chromosome 11 in tumors from patients with multiple endocrine neoplasia syndrome type 1. Cancer Res., 50; 6529-6533, 1990.
10. Bystrom, C., Larsson, C., Blomberg, C., Sandelin, K., Falkmer, U., Skogseid, B., Oberg, K., Werner, S., and Nordenskjold, M. Localization of the MEN1 gene to a small region within chromosome 11q13 by deletion mapping in tumors. Proc. Natl. Acad. Sci. USA, 87: 1968-1972, 1990.
11. Bale, A. E., Norton, J. A., Wong, E. L., Fryburg, J. S., Maton, P. N., Oldfield, E. H., Streeten, E., Aurbach, G. D., Brandi, M. L., Friedman, E., et al. Allelic loss on chromosome 11 in hereditary and sporadic tumors related to familial multiple endocrine neoplasia type 1. Cancer Res., 51: 1154-1157, 1991.
12. Ballard, H. S., Frame, B., and Hartsock, R. J. Familial multiple endocrine adenomapeptic ulcer complex. Medicine, 43: 481-516, 1964.
13. Darling, T. N., Skarulis, M. C., Steinberg, S. M., Marx, S. J., Spiegel, A. M., and Turner, M. Multiple facial angiofibromas and collagenomas in patients with multiple endocrine neoplasia type 1. Arch. Dermatol., 133: 853-857, 1997.
14. Burgess, J. R., Harle, R. A., Tucker, P., Parameswaran, V., Davies, P., Greenaway, T. M., and Shepherd, J. J. Adrenal lesions in a large kindred with multiple endocrine neoplasia type 1. Arch. Surg., 131: 699-702, 1996.
15. Duh, Q. Y., Hybarger, C. P., Geist, R., Gamsu, G., Goodman, P. C., Gooding, G. A., and Clark, O. H. Carcinoids associated with multiple endocrine neoplasia syndromes. Am. J. Surg., 154: 142-148, 1987.
16. Chandrasekharappa, S. C., Guru, S. C., Manickam, P., Olufemi, S. E., Collins, F. S., Emmert-Buck, M. R., Debelenko, L. V., Zhuang, Z., Lubensky, I. A., Liotta, L. A., Crabtree, J. S., Wang, Y., Roe, B. A., Weisemann, J., Boguski, M. S., Agarwal, S. K., Kester, M. B., Kim, Y. S., Heppner, C., Dong, Q., Spiegel, A. M., Burns, A. L., and Marx, S. J. Positional cloning of the gene for multiple endocrine neoplasia-type 1. Science (Washington DC), 276: 404-407, 1997.
17. Lemmens, I., Van de Ven, W. J., Kas, K., Zhang, C. X., Giraud, S., Wautot, V., Buisson, N., De Witte, K., Salandre, J., Lenoir, G., Pugeat, M., Calender, A., Parente, F., Quincey, D., Gaudray, P., de Wit, M. J., Lips, C. J., Hoppener, J. W., Khodaei, S., Grant, A. L., Weber, G., Kytola, S., Teh, B. T., Farnebo, F., and Thakker, R. V. Identification of the multiple endocrine neoplasia type 1 (MEN1) gene. The European Consortium on MEN1. Hum. Mol. Genet., 6: 1177-1183, 1997.
18. Bassett, J. H. D., Forbes, S. A., Pannett, A. A. J., Lloyd, S. E., Christie, P. T., Wooding, C., Harding, B., Besser, G. M., Edwards, C. R., Monson, J. P., Sampson, J., Wass, J. A. H., Wheeler, M. H., and Thakker, R. V. Characterization of mutations in patients with multiple endocrine neoplasia type 1. Am. J. Hum. Genet., 62: 232-244, 1998.
19. Eubanks, P. J., Sawicki, M. P., Samara, G. J., Wan, Y. J., Gatti, R. A., Hurwitz, M., and Passaro, E. J. Pancreatic endocrine tumors with loss of heterozygosity at the multiple endocrine neoplasia type I locus. Am. J. Surg., 173: 518-520, 1997.
20. Chakrabarti, R., Srivatsan, E., Wood, T. F., Eubanks, P. J., Ebrahimi, S., Gatti, R. A., Passaro, E., and Sawicki, M. P. Deletion mapping of endocrine tumors localizes a second tumor suppressor gene on chromosome 11q13. Genes Chromosomes Cancer, 22: 130-137, 1998.
21. Oto, M., Miyake, S., and Yuasa, Y. Optimization of nonradioisotopic single strand conformation polymorphism analysis with a conventional minislab gel electrophoresis apparatus. Anal. Biochem., 213: 19-22, 1993.
22. Zhuang, Z., Vortmeyer, A. O., Pack, S., Huang, S., Pham, T. A., Wang, C., Park, W., Agarwal, S. K., Debelenko, L. V., Kester, M., Guru, S. C., Manickam, P., Olufemi, S., Yu, F., Heppner, C., Crabtree, J. S., Skarulis, M. C., Venzon, D. J., Emmert-Buck, M. R., Spiegel, A. M., Chandrasekharappa, S. C., Collins, F. S., Burns, A. L., Marx, S. J., Jensen, R. T., Liotta, L. A., and Lubensky, I. A. Somatic mutations of the MEN1 tumor suppressor gene in sporadic gastrinomas and insulinomas. Cancer Res., 57: 4682-4686, 1997.
23. Heppner, C., Kester, M. B., Agarwal, S. K., Debelenko, L. V., Emmert-Buck, M. R., Guru, S. C., Manickam, P., Olufemi, S-E., Skarulis, M. C., Zhuang, Z., Liotta, L. A., Chandrasekharappa, S. C., Collins, F. S., Spiegel, A. M., Burns, A. L., and Marx, S. J. Somatic mutation of the MEN1 gene in parathyroid tumours. Nat. Genet., 16: 375-378, 1997.
24. Merlo, A., Herman, J. G., Mao, L., Lee, D. J., Gabrielson, E., Burger, P. C., Baylin, S. B., and Sidransky, D. 5′ CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancers. Nat. Med., 1: 686-692, 1995.
25. Herman, J. G., Latif, F., Weng, Y., Lerman, M. I., Zbar, B., Liu, S., Samid, D., Duan, D. S., Gnarra, J. R., and Linehan, W. M. Silencing of the VHL tumor-suppressor gene by DNA methylation in renal carcinoma. Proc. Natl. Acad. Sci. USA, 91: 9700-9704, 1994.
26. Schroeder, M., and Mass, M. J. CpG methylation inactivates the transcriptional activity of the promoter of the human p53 tumor suppressor gene. Biochem. Biophys. Res. Commun., 235: 403-406, 1997.
27. Yoshiura, K., Kanai, Y., Ochiai, A., Shimoyama, Y., Sugimura, T., and Hirohashi, S. Silencing of the E-cadherin invasion-suppressor gene by CpG methylation in human carcinomas. Proc. Natl. Acad. Sci. USA, 92: 7416-7419, 1995.
28. Graff, J. R., Herman, J. G., Myohanen, S., Baylin, S. B., and Vertino, P. M. Mapping patterns of CpG island methylation in normal and neoplastic cells implicates both upstream and downstream regions in de novo methylation. J. Biol. Chem., 272: 22322-22329, 1997.
29. Stirzaker, C., Millar, D. S., Paul, C. L., Warnecke, P. M., Harrison, J., Vincent, P. C., Frommer, M., and Clark, S. J. Extensive DNA methylation spanning the Rb promoter in retinoblastoma tumors. Cancer Res., 57: 2229-2237, 1997.
30. Debelenko, L. V., Brambilla, E., Agarwal, S. K., Swalwell, J. I., Kester, M. B., Lubensky, I. A., Zuang, Z., Guru, S. C., Manickam, P., Olufemi, S., Chandrasekharappa, S. C., Crabtree, J. S., Kim, Y. S., Heppner, C., Burns, A. L., Spiegel, A. M., Marx, S. J., Liotta, L. A., Collins, F. S., Travis, W. D., and Emmert-Buck, M. R. Identification of MEN1 gene mutations in sporadic carcinoid tumors of the lung. Hum. Mol. Genet., 6: 2285-2290, 1997.